CLL SOCIETY:

THIS WEEK

November 1, 2022

SPECIAL FEATURE: Committing to Diversity, Equity, and Inclusion

"At CLL Society, we believe all individuals impacted by chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) deserve equitable access to quality education, support, and care."

We know there is much work still to do to achieve equity in care for every individual living with CLL/SLL, regardless of their identity. CLL Society is working tirelessly to break down barriers to care and improve the lives of all impacted by CLL/SLL. Our Commitment to Diversity, Equity, and Inclusion (DEI) and Values Statements were developed to demonstrate our commitment and we promise to hold ourselves accountable and keep learning together.

Read the full statements on our website

WHAT'S NEW IN CLL/SLL

ASCO 2022: Lisaftoclax, a Novel BCL-2 Inhibitor in Patients with Relapsed/Refractory CLL

Lisaftoclax is an experimental BCL-2 inhibitor similar to venetoclax that is being tested in clinical trials to determine if a faster ramp-up in dosing is possible. Venetoclax is currently the only approved BCL-2 inhibitor for CLL/SLL, but its required slow ramp-up can be inconvenient and in some cases insufficient for patients.

COVID-19 UPDATES

ASH 2021: Dr. Jake Soumerai on the Immune Response to COVID-19 Vaccination in Patients With CLL

While antibody levels are one measure of response to COVID-19 vaccination, they do not tell the whole story. The immune response has a lot of other important parts that are involved. Watch our interview with Dr. Jake Soumerai to learn about a new study that looked at the immune response to COVID-19 vaccines in a more comprehensive way.

UPCOMING EVENTS

6th Annual CLL/SLL Patient & Caregiver Ed Forum

Wednesday, November 16, 2022 at 9:30 AM PT / 10:30 AM MT / 12:30 PM ET

In partnership with Huntsman Cancer Institute (HCI), CLL Society invites you to attend our virtual Ed Forum. Featured speakers will present the basics of CLL/SLL diagnosis, testing, early management, the importance of secondary cancer screenings, vaccination information, and staying health through diet and exercise. Speakers will also provide an overview of CLL treatment options and clinical trials, as well as strategies to becoming an effective self-advocate from the patient perspective.

EDUCATION ON-DEMAND

Playing CLL/SLL Chess: Planning Your Therapy Moves

If you missed the recent webinar on how to plan for various CLL/SLL treatments with Dr. Susan O'Brien and patient advocate Terry Evans, you can catch the replay here!

Watch Now

LIVING WITH CLL/SLL

New Watch & Wait Support Group

CLL Society is launching two Watch & Wait Support Groups to accommodate the high demand for this group. CLL/SLL patients and caregivers are welcome to join either group, which are named Eastern and Western based on time zone convenience. The first meetings will take place in December and the groups will meet on a bi-monthly basis. We encourage people to also join a local CLL Society Support Group with members who have treatment experience for their CLL/SLL, as there is great value in learning from people who are on or have received different treatments.

Learn More

Support CLL Society

The end of the year is nearing and it is the perfect time to incorporate CLL Society into your financial planning. CLL Society graciously accepts planned gifts from Donor Advised Funds, from an IRA as a qualified charitable distribution, gifts of appreciated stock, beneficiary designations in a will or retirement account, and more. Learn how you can leave a meaningful legacy today that will help those impacted by CLL/SLL for many years to come.

Your support of the mission of CLL Society not only contributes to making credible support and education resources available, but you are a part of funding research for a cure to CLL/SLL!

CLL Society is invested in your long life. Please invest in the long life of the CLL Society by supporting our work.

Donate Today

Learn About Planned Giving

Looking to Join a Support Group?

CLL Society Support Groups are located around the US and Canada and focus exclusively on the needs of people living with or caring for someone with chronic lymphocytic leukemia (CLL). The groups provide mutual support, learning opportunities, patient-friendly and physician-reviewed information, and the opportunity to discuss anxieties and concerns with others.

Please note, all meetings take place virtually since the onset of the COVID-19 pandemic.

Join a CLL Society Support Group

CLL Society would like to thank Regeneron, Pharmacyclics, and Janssen for supporting our ongoing efforts to bring CLL patients the latest information on COVID-19.

CLL Society

www.cllsociety.org

support@cllsociety.org

1454 Melrose Ave., Ste 1-247

Chula Vista, CA 91911